The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5089
Abstract: Breast cancer (BC) remains the leading cause of cancer‐related deaths worldwide. High recurrence risk Luminal BC receives adjuvant chemotherapy in addition to standard hormone therapy. Considering the heterogeneity of Luminal B BC, a more accurate… read more here.
Keywords: regrouping luminal; her2 negative; luminal her2; recurrence ... See more keywords
Multiparametric MRI Features of Breast Cancer Molecular Subtypes
Sign Up to like & getrecommendations! Published in 2022 at "Medicina"
DOI: 10.3390/medicina58121716
Abstract: Background and Objectives: Breast cancer (BC) molecular subtypes have unique incidence, survival and response to therapy. There are five BC subtypes described by immunohistochemistry: luminal A, luminal B HER2 positive and HER2 negative, triple negative… read more here.
Keywords: molecular subtypes; luminal her2; breast; her2 ... See more keywords